Trabajos de investigación

Ctrl-X, Ctrl-C and Ctrl-V in Veterinary Dermatology: skin microbiota transplantation as a promising approach for dogs with cutaneous adverse food reactions

Ctrl-X, Ctrl-C y Ctrl-V en Dermatología Veterinaria: el trasplante de microbiota cutánea como un enfoque prometedor para perros con reacciones cutáneas adversas a los alimentos

Ural, Kerem; Erdoğan, Hasan; Erdoğan, Songül

Kerem Ural

uralkerem@gmail.com

Department of Veterinary Internal Medicine, Faculty of Veterinary Medicine, Aydın Adnan Menderes University Turquía

Hasan Erdoğan

Department of Veterinary Internal Medicine, Faculty of Veterinary Medicine, Aydın Adnan Menderes University Turquía

Songül Erdoğan

Department of Veterinary Internal Medicine, Faculty of Veterinary Medicine, Aydın Adnan Menderes University Turquía

Analecta Veterinaria

Universidad Nacional de La Plata, Argentina

ISSN: 0365-5148

ISSN-e: 1514-2590

Periodicity: Frecuencia continua

vol. 44, e080, 2024

analecta@fcv.unlp.edu.ar

Received: 07 July 2023

Accepted: 19 December 2023

URL: http://portal.amelica.org/ameli/journal/25/254942254942001/

DOI: https://doi.org/10.24215/15142590e080

License Creative Commons
This work is licensed under Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.

Non-profit publishing model to preserve the academic and open nature of scientific communication

ePub generated from XML JATS4R

Abstract: The probability of influencing the skin microbiome for addressing skin disorders opens a novel aisle of therapy. This study aimed to evaluate the efficacy of skin microbiota transplantation (sMt) for cutaneous adverse food reactions (caFr) in dogs. Ten client-owned dogs with caFr were included in the study. Unenriched heterologous sMt was performed using Nivea Skin Refining Clear-Up Strips (N-cUs). The bacterial microbiota of skin samples was analysed by next-generation sequencing of the 16S rRNA gene. Other relevant biomarkers were involved in VAS (visual analogue scale of pruritus score), CADESI-04 (canine atopic dermatitis extent and severity index) and epidermal corneometric analysis. Increased Faecalibacterium (0 to 1.9 %), Peptoclostridium (5.49 % to 9.11 %) and Collinsella (0.65 % to 8.91 %), and decreased Fusobacterium (19.16 % to 9.06 %), Porphyromona (8.75 % to 0.13 %), Streptococcus (1.63 % to 0.14 %) and Staphylococcus (1.09 % to 0.49 %) was evidenced before and after sMt, respectively. Treatment with sMt effectively controlled clinical signs and drastically reduced median VAS pruritus (6.5 vs. 2) and CADESI-04 scores (74.50±22.62 to 19.30±11.30) (p<0,001). In addition, skin pH and hydration values were improved (p<0,001) after sMt. The heterologous and unenriched sMt with N-cUs could be responsible for the clinical recovery observed in this study.

Keywords: atopic dermatitis, food intolerance, microbiota, skin, transfer.

Resumen: La probabilidad de influir en el microbioma de la piel para abordar trastornos dermatológicos abre una nueva vía de terapia. El objetivo del presente trabajo fue evaluar la eficacia del trasplante de microbiota cutánea (sMt) en diez perros con reacciones en piel, adversas a los alimentos (caFr). Se realizó un sMt heterólogo no enriquecido mediante el uso de tiras clarificadoras Nivea Skin Refining Clear-Up (N-cUs). Se prefirió la secuenciación de próxima generación para investigar la microbiota bacteriana en las muestras de piel de los animales estudiados. Otros biomarcadores relevantes estuvieron involucrados en la puntuación de prurito VAS, CADESI-04 y análisis corneométrico epidérmico (hidratación y pH). El gen 16S rRNA clasificó con éxito la presencia de un aumento de Faecalibacterium (0 a 1,9%), Peptoclostridium (5,49 % a 9,11 %) y Collinsella (0,65 % a 8,91 %), mientras que se observó una disminución de Fusobacterium (19,16 % a 9,06 %), Porphyromonas (8,75 % a 0,13 %), Streptococcus (1,63 % a 0,14 %) y Staphylococcus (1,09 % a 0,49 %), antes y después del sMt. El tratamiento con sMt controló eficazmente los signos clínicos y redujo drásticamente la mediana del prurito VAS (6,5 vs. 2) y las puntuaciones CADESI-04 (74,50±22,62 a 19,30±11,30) (p<0,001). Además, tanto el pH de la piel como los valores de hidratación se vieron alterados (p<0,001) después del sMt. El sMt heterólogo y no enriquecido con N-cUs podría ser responsable de la recuperación clínica observada en este estudio

Palabras clave: dermatitis atópica, intolerancia alimentaria, microbiota, piel, transferencia.

Introduction

The “hygiene hypothesis” connected premature vulnerability to microbes to the existence of allergic conditions, including food allergies (Schaub et al., 2006). This phenomenon suggested that microbial exposure during infancy can educate the immune response, resulting in accurate maturation and diminished deviation of the immune response later in life. Arousing interest has been shown in the importance of gut and skin microbiota transplantation (sMt) in health and disease conditions. Considering the hygiene hypothesis, two stages of life (i.e. infancy and untimely childhood) appear as crucial moments for the establishment of microbial colonization, immune response, and potential systemic disease. The skin and gut microbiomes are vital during this process (Hammond et al., 2021). Several cutaneous disorders are related to an unbalanced skin microbiome. Investigation on the integumentary microbiota has gained arousing interest (i.e. therapeutical and cosmetic targeted approach) in which several studies denoted entanglement of the cutaneous ecology of humans, dogs, and cats (Dréno et al., 2016; Liang et al., 2021; Tizard & Jones, 2018). Countless interplay between the cutaneous microbiota and the immune system have been well recognized, in which a diverse and balanced microbiota is crucial for healthy skin (Liang et al., 2021).

To the best of our knowledge, both skin microbiota alterations and manipulation of skin dysbiosis in cutaneous adverse food reactions (caFr) among dogs have not been reported with detailed clinical analysis. This prompted us to perform this study in which heterologous unenriched skin microbiota transplantation (sMt) was applied to 10 dogs with caFr, to change the cutaneous microenvironment, along with searching for alternative strategies for cutaneous disorders.

Materials and methods

Declarations-ethics approval

Dogs participating in this study were all referred to the University of Adnan Menderes, Faculty of Veterinary, Department of Internal Medicine, Small Animal Clinics. All dogs were clinically examined for disease state. Microbiome samples used for this analysis were collected with written owner consent. Owners were aware that sMt was performed for research purposes only. The present study was approved by the local ethics committee of Aydın Adnan Menderes University-HADYEK with number 64583101/2019/022 and the owners provided their consent, having been fully informed, to participate in this study.

Subjects included and study design

A total of 10 skin swab samples were analysed. The timeline included day 0 assigned as before sMt and day 21 as after sMt with N-cUs. All dogs resided in Aydin Municipality where the faculty is located. Ten dogs, from different ages (2 to 6 years old) were included. Relevant data regarding breed, age, gender, and medical records were recorded. All 3 researchers along with assistants (from a group of PhD and Master of Science Students) triaged, examined, and organized the animals eligible to participate in the study. All cases were diagnosed with caFr by i) confirmation through a positive challenge, which was followed by an elimination diet (including both phases of restriction and then provocation) (Martín et al., 2004; Olivry & Mueller, 2019) ii) clinical background and iii) reduction of pruritus following an elimination diet (novel hydrolyzed protein-based diet with low carbohydrate, 17 %) lasting at least 6 weeks (Rondelli et al., 2015). During the study, dogs did not receive any drug or treatment capable of interfering with the results. Allergen-specific serum immunoglobulin (Ig) E was measured using Polycheck in vitro Allergen Testing Cassettes (.Polycheck Allergy Diagnostics, Germany), to support and identify suitable ingredients for an elimination diet trial (Tang et al., 2020). Epidermal corneometric analysis (skin pH and hydration) was evaluated using the Callegari Soft Plus Device (.Callegari, Italy). Other relevant diseases for differential diagnosis were ruled out by routine biochemistry, endocrinology, haematology, skin cytology and dermatological examination.

Microbiota analysis

Sample collection, DNA extraction, library preparation, and sequencing

Samples were analysed by next-generation sequencing to determine both the relative and absolute presence of bacteria before (day 0) and after (day 21) treatment. Samples were collected with a swab collection kit (MiDOG LLC service). Before sMt, swab samples were collected from skin lesions, and thereafter sMt was performed onto the lesional skin. On day 21, samples were collected from the same topographical location with a sterile, DNA-free swab included in the collection kit (twisting off and twirling the swab 10 times over the lesion). Then, the swab tip was broken off into a sterile tube pre-filled with a DNA/RNA preservative (Tang et al., 2020; Ural et al., 2022; Ural et al., 2023). All samples were then shipped for processing to the MiDOG LLC testing center (Irvine, California).

Genomic DNA was obtained through ZymoBIOMICS™-96 DNA kit (Zymo Research Corp.) with a Hamilton Star. liquid handling robot (Hamilton Company, Reno, NV) (Rondelli et al., 2015). Sample library procedures and relevant informatic analytes regarding bacterial profiling were performed by using the Quick-16S NGS Library Prep Kit (Zymo Research Corp.). The 16S rDNA V1-V3 region was targeted for bacterial analysis. Primer sequences were established on the MiDOG LLC service. Other relevant methodologies were as described elsewhere. Profiles of microbiota were established through MiDOG LLC bioinformatics analysis pipeline. Entire phylotyping was computerized through percentage proportions considering the total number of sequences in each skin sample (Tang et al., 2020).

Methods of evaluation of the efficacy of sMt in dogs with cutaneous adverse food reactions

The canine atopic dermatitis extent and severity index fourth version (CADESI-04) was used to evaluate the lesions (Olivry et al., 2014). Furthermore, to evaluate the severity of pruritus, the Visual Analogue Scale of pruritus scoring (VAS) was used, composed of the full range of possible values (0 to 10) (Rybníček et al., 2009).

Skin microbiota transplantation by use of N-cUs

The same research group developed a previous methodology of both heterologous and autologous origin of sMt based on unenriched sMt (Ural et al., 2022, 2023). Changing the local microbiome (with possible different effects on the whole skin widespread) with a heterologous origin of sMt was hypothesized, and all skin samples for microbiota analysis were withdrawn from the transplant site. Day 0 was planned as referral (initial sampling without any application) whereas day 21 was preferred as second sampling (after sMt data). Allocation days (days 0, 5, and 12) were selected based on several transplantations, based on our previous experience (Ural et al., 2022, 2023). The evidence-based data indicated that tape-stripping removal of skin produced a newly existing skin microbiome with similarities to deeper stratum corneum layers for up to 2 weeks (Zeeuwen et al., 2012). Briefly, five of 10 dogs received three sMt on days 0, 5 and 12, four dogs received two sMt on days 0 and 5, and one dog received un sMt on day 0. The number of sMt procedures was based on algorithmic decision and observation of researchers through evidence of limited novel hair growth (via DermLite DL4 dermatoscopy) and decreased erythema and supported by previous studies (Ural et al., 2022, 2023).

A total of three healthy dogs were selected as sMt donors after screening for disease status, serum biochemistry, endocrinology, and haematology. The dogs were also checked for skin and gut microbiota analysis. No clinically relevant pathogen was detected, nor disease state was evident during the trial. In each case, at least one of the N-cUs was unboxed, and every single strip was detached. Four apparent healthy areas of skin with normal hair growth and no visible lesions were selected (Figures 1a and 1b). Strips moistened in lactated Ringer's solution (with a skin-appropriate pH of 6.5) were placed over the partially clipped areas (CUT) and allowed to adhere (COPY) for twelve minutes (Figure 1c and 1d). All strips were then transferred to the diseased and moistened skin (Figure 1e) and allowed to adhere (PASTE) for at least 15 minutes (Ural et al., 2022, 2023). Finally, all strips were removed. None of the dogs were bathed during the trial. Unpleasant side effects involving urticaria and suddenly appearing erythema were monitored for possible existence.

Figure 1

Skin microbiota transplantation (sMt) for cutaneous adverse food reactions in dogs. Three different stages of unenriched sMt: a-b) clipping of donor (CUT), c-d) heterologous origin of copying skin microbiota through N-cUs (COPY), and finally e) recipient transplantation of unenriched skin microbiota through N-cUs (PASTE).

Statistical analysis

Quantities of α-diversity and evenness and quantity of observed species were estimated using the Shannon index. CADESI-04, VAS pruritus, skin pH and hydration were reported as mean and standard deviation. Statistical comparisons before and after treatment were evaluated using the Mann-Whitney U test (GraphPad Prism, Version 9).

Results

Demographic data

Demographic data including sex, breed, age, and number of sMt procedures are shown in Table 1. The number of sMt procedures depended on clinical scoring, epidermal corneometric analysis and response to the first sMt procedure. Five out of 10 cases received a maximum of three sMt procedures, after which clinical response was evident, and no more applications were deemed necessary. CADESI-04 scores particularly served as a guide for further sMt procedure; if the latter decreased, sMt was not continued.

Table 1

Skin microbiota transplantation sMt for cutaneous adverse food reactions in dogs

| Total (n=10) | Post-sMt skin condition noted (n = 3) | No post-sMt skin condition noted (n = 7)
Sex n (%) |  |  |
-male | 6 | 1 | 5
-female | 4 | 1 | 3
Breed (age) |  |  |
Pomeranian | 2 (2-4 years) | - | 2
Maltese Terrier | 2 (1-2 years) | - | 2
French Bulldog | 1 (4 years) | - | 1
Crossbred | 5 (3-6 years) | 2 | 3
Number of sMt procedures per patient, n (%) |  |  |
-one | 2 | 0 | 2
-two | 3 | 1 | 2
-three | 5 | 1 | 4

Demographic data of dogs enrolled in the study

Microbial composition before and after sMt

The microbial composition at different time points, before and after sMt is shown in Figure 2a. Microbiota analysis before and after sMt treatment, respectively, revealed that, at the phylum level, Firmicutes were the most abundant (32.98 % vs. 32.90 %) followed by Fusobacteria (22.28 % vs. 13.25 %), Bacteroidetes(19.54 % vs. 21.09 %), Proteobacteria (3.74 % vs. 3.50 %) and Actinobacteria (2.24 % vs. 10.92 %). Unless stated otherwise average relative abundances are reported. Full-length analysis of the 16S rRNA gene successfully classified the dominant bacteria at species level. The taxa comprising the canine skin microbiota studied included unclassified Actinobacteria (1.59 %), an unclassified, unknown species belonging to the family Fusobacteriales (3.11 %), an unclassified species belonging to the family Lachnospiraceae (5.3 %) and Prevotellaceae (1.54 %) (Figure 2a). In addition, the presence of Fusobacterium (19.16 %), Peptoclostridium (5.49 %), Blautia (7.39 %), Porphyromonas (8.75 %) and Bacteroides (9.1 %) were determined at the genus level in the pre-treatment period. Remarkably, in the genus-based evaluation following sMt, evidenced presence of increased Faecalibacterium [0 to 1.9 %], Peptoclostridium [5.49 % to 9.11 %] and Collinsella [0.65 % to 8.91 %], and decreased Fusobacterium [19.16 % to 9.06 %], Porphyromonas [8.75 % to 0.13 %], Streptococcus [1.63 % to 0.14 %] and Staphylococcus [1.09 % to 0.49 %] was evidenced. Microbiota variation (median observed species) changed from 25 to 42.5 (Figure 2b). Hence, to differentiate disease and health status of each dog enrolled, categorization was based on their bacterial diversity. 110 long-read DNA sequencing was applied to a subset (n = 11) of the clinical samples, in which following sMt, healthier dogs exhibited greater species diversity. Compared to initial values (before sMt) there was a significant loss inα-diversity detected by using the Shannon Index mean values (4.847 vs. 5.43, p <0.01) (Figure 2b).

Figure 2

a) Distribution of bacterial species before and after skin microbiota transplantation (sMt) for treatment of adverse skin reactions to food in dogs. The bacterial species represented by sequence code are colour-coded and are valid across columns. b) Shannon index (mean) for measurements of α-diversity before (BT) and after (AT) sMt.

Clinical biomarkers for remission/recovery

Clinical parameters evaluated are reported in Figures 3 and Table 2. Treatment with sMt positively/effectively diminished clinical signs associated with caFr and drastically reduced median VAS pruritus (6.5 vs. 2 p<0,001) and mean ± SD) CADESI-04 scores (74.50±22.62 to 19.30±11.30) (p<0,001). In addition, median values for skin pH (5.4 vs. 7.1) and hydration (24 vs. 84.5) denoted altered skin barrier functioning, before and thereafter sMt treatment, respectively, (p<0,001) (Table 2). Clinical records of selected cases are shown in figures 4, 5A and 5B.

Figure 3

Epidermal corneometric interpretation before and after sMt for dogs with cutaneous adverse food reactions. A: VAS pruritus; B: Cadesi-04; C: Skin pH; D: Skin hydration.

Table 2

Skin microbiota transplantation sMt for cutaneous adverse food reactions in dogs

| CADESI-04 | VAS Pruritus | Skin pH | Skin Hydration
| Median | 97.85% CI | Median | 97.85% CI | Median | 97.85% CI | Median | 97.85% CI
Before treatment | 74.50 ± 22.62 | 50-101 | 6.5 | 5-9 | 5.4 | 4.8-6.6 | 24 | 6-55
After treatment | 19.30 ± 11.30 | 11-30 | 2 | 0-4 | 7.2 | 6.7-7.6 | 84.5 | 66-100
| P=0.001 | p<0.001 | p<0.001 | p<0.001

Dermatological scoring data used in this study presented median values along with 97.85 % CI. p<0.05 statistically important

Figure 4

Skin microbiota transplantation (sMt) for cutaneous adverse food reactions in dogs. Appearance of case 1 before and after sMt (week 3).

Figure 5

Baseline and treatment characteristics of two cases (A y B) at day 0 and week 6.

Discussion

The present study herein describes the successful treatment of primary and/or secondary skin lesions due to caFr in dogs using unenriched sMt of heterologous origin, as evidenced by a) decreased pruritus VASand CADESI-04 scores and b) altered skin microbiota as shown by increased mean observed species and changes in skin microbiota composition. Following sMt, Firmicutes, Fusobacteria and Proteobacteria abundances were decreased, whereas Bacteriodetes and Actinobacteria relative abundances were elevated. Interestingly Actinobacteriaabundance was strikingly high after sMt (2.24 % vs. 10.92 %), in contrast to previous reports. Similarly, to human cutaneous ecology, the most abundant phyla detected among dogs were Proteobacteria, Firmicutes, Actinobacteria, and Bacteroides. On the other hand, given that Actinobacteria prevails in humans whilst it is slightly more abundant among dogs (Costello et al., 2009; Grice et al., 2008; Grice & Segre, 2011; Rodrigues Hoffmann et al., 2014), in the present study, following sMt, recovered dogs showed greater abundance of Actinobacteria and mildly increased abundance of Bacteriodetes. Although not shown, Corynebacteriales and Coriobacteriales orders were the vast majority of Actinobacteria phylum following sMt application. Interestingly, although not surprisingly, at the genus level average relative abundances of Streptococcus (1.63 % to 0.14 %) and Staphylococcus (1.09 % to 0.49 %) were all decreased following sMt. This could be related to the recovery of skin among dogs, with withdrawal of clinical signs.

Given the microbial composition in different skin regions among humans, with Staphylococcus and Corynebacterium spp. predominating in moist areas (Griece et al., 2009), and Corynebacteria being members of the healthy cutaneous microecology, it is quite strenuous to differentiate among infection, colonization, and contamination even if the latter agents are isolated from purulent material (Esteban et al., 1999). Further studies are necessary to clarify the role of Corynebacteria in healthy skin. Another possible explanation is that the movement of unenriched microbiota by use of N-cUs possibly transferred and relocated the entire cutaneous microenvironment from donor to diseased dogs in the present study.

Skin microbiota transplantation in dogs is still in its infancy, with little published evidence and few clinical trials reported, which unfortunately limits its use, and the extent of application by veterinarians remains unknown. In the present research, treatment with sMt was found to effectively control/manage signs of caFr and drastically reduce median VAS pruritus (Table 2, Figure 3a) in the absence of any immunosuppressive drug and/or antibiotic usage. Furthermore, clinical recovery was also supported by epidermal corneometric analysis Median values for skin pH and hydration selectively denoted altered skin barrier functioning, before and after sMt treatment. This efficacy was also related to sMt application. Cutaneous adverse food reactions negatively affected skin barrier functioning, as before treatment median pH and hydration values were improved after treatment (Table 2). Since the association between abnormal pH and skin diseases has been reported, all clinical analyses observed in this study should at least partly explain the role of sMt in supporting skin barrier integrity.

To the authors’ knowledge, no previous research to date has investigated the likelihood of conducting a skin microbiota transplant capable of moving the entire integumentary bacterial community, along with its complex network of metabolic interactions (Perin et al., 2019). The importance of relocating a community is based on the condition that several members of the microbiome require their community partner (selected microbes counteract with obligately mutualistic metabolism, oftentimes denoted as syntropy, or cross-feeding fashion of living) (Morris et al., 2013). According to the human gut microbiome analysis, there is emerging proof of cross-feeding in commensal bacteria to produce bioactive short-chain fatty acids among healthy hosts (D’hoe et al., 2018; Hoek & Merks, 2017; Louis & Flint, 2017).

The use of unenriched sMt in this study may potentially be considered a matter of concern. Elevated amounts of bacterial DNA were present in hair follicles in contrast to the epidermis. Bacterial DNA was also present in the dermis and adipose tissue, although the viability of those bacteria remains unclear (Bay et al., 2013; Nakatsuji et al., 2013;). Taking this into account, it was hypothesized that the microbiome belonging to deeper layers of skin is the core skin microbiome (Callewaert et al., 2021). We clipped a limited portion of skin among donor dogs, to prevent probable bacterial DNA existing in hair follicles. N-cUs produced and launched for confiscation of blackheads on the T-Zone were specifically used for sMt, like what has been described elsewhere (Ural et al., 2022, 2023). The latter strips are capable of effectively removing waste material, through activation with water, attaching with dirt, and therefore cleaning superficial skin. Its content of citric acid, capable of trimming superficial layers of old skin tissue, may have helped recovery observed in this study, like what has been reported previously (Ural et al., 2023). Citric acid was responsible for inhibiting Pseudomonas ceramidase which consequently suppressed inflammation in atopic dermatitis (Inoue et al., 2010). Given this data, citric acid involved in N-cUs used in this study may have helped the regression of clinical signs through this mechanism. Moreover, citric acid supplementation played a pivotal role in lowering the pH of the intestinal tract, by reducing the population of pathogenic bacteria, specifically E.coli (as it is highly sensitive to acidity), through mechanisms of penetrating pathogenic cell walls leading to suppression of their growth/reproduction (Russel & Diez-Gonzalez, 1998), whilst elevating the number of beneficial bacteria (Gunal et al., 2006), capable of modulating bacterial cell cytoplasmic enzymes and transport systems preparing cells being resistant to osmotic pressure (Cho & Finocchiaro, 2010). Furthermore, in the present study, a relative abundance of E. coli was 2.8 to 8.2 % in 6 out of 10 dogs and shifted to 0 to 0.1 % following sMt. We might conclude that the N-cUs might probably display antimicrobial behaviour against pathogens, whereas support the growth of beneficial bacteria.

A previous study reported by our group (Ural et al., 2022) involving two clinical cases evidenced the beneficial usage of transferring unenriched skin microbiota niches between two heterologous hosts, defined as heterologous skin microbiota transplantation (hSmT). In that study, hSmT involved transfer by use of N-cUs between healthy donors to two different dogs, with scabies. VAS pruritus scores were diminished markedly from day 0 (initial hSmT day) to day 21. Skin scrape was negative after day 2 of hSmT and remained negative throughout the study. Unenriched skin microbiota transplantation from a healthy donor to the dogs with scabies, resulted in clinical and parasitological recovery through modification of the cutaneous microenvironment, without any drug application. Another study (Ural et al., 2023) examined the feasibility of sMt via N-cUs for transferring unenriched skin microbiota communities, to investigate its influence on erythema scores. In this study, four different healthy anatomical locations in each case (autologous) were selected, where the strips were placed (Ctrl C), and then moved (Ctrl V) to the skin tissue with erythema, repeating the procedure on days 5 and 12. The skin erythema severity and atopic dermatitis area and severity index were all statistically decreased throughout the study, likely due to the efficacy of sMt.

However, some limitations may be mentioned in our study. We do not know (still at the time of writing) the viability of transferred bacteria on N-cUs. Furthermore, the longevity of sMt strips is also unknown. However, given that the tape-stripping method for collecting viable skin bacteria previously described resulted in accurate skin microbiome composition (Ogai et al., 2018) and higher alpha diversity (Rungjang et al., 2022), N-cUs could have helped transfer beneficial bacteria or bacterial DNA immediately in the present study. As this was not the primary objective of this study, test strips were not sent for microbiome analysis. As clinicians we prioritized to transfer test strips immediately, so we found no opportunity to divide test strips for interpretation. Hence, we also could not show the movement of DNA from donors to diseased dogs. In a previous study conducted in humans by Perin et al. (2019), the DNA of several of the unique, rare-arm bacteria remained in their novel back environment for a day, and an abrupt drop in this signal was observed. The researchers could not identify the likely causes of the collapse of these bacteria for colonizing the recipient site. On the other hand, although we did not recognise transfer material microbiome, in the present study, we showed evidence of transfer dynamics as skin microbiome analyses were performed. Furthermore, increased median observed species as detected by skin microbiota analysis, along with clinical recovery without any usage of drug or nutraceuticals partially showed evidence that beneficiary bacteria should have relocated to treated areas. This limitation should be further investigated, and future research could improve the interpretation of the viability of transferred bacteria.

Conclusions

This study provides evidence that it is possible to relocate the cutaneous microenvironment from donor to diseased dogs (Ctrl X, Ctrl C and Ctrl V). Future studies should be aimed at analysing the viability and colonization success of transferred skin microbiomes between the different sites of two dissimilar individuals.

Unfortunately, due to insufficient project financial support, we were unable to analyse the microbiota evident on N-cUs, which remains the aim of our next study. It is possible to suggest that citric acid could have helped lower cutaneous pH and consequently caused bacterial death due to suppression of the NADH, or, alternatively, modified local epidermal pH (Su et al., 2014) which could be responsible for antimicrobial behaviour and microbiota changes observed at this study. The Shannon index values and median observed species, before and after sMt, likely support this hypothesis.

Acknowledgements

Collected samples were shipped for processing to the MiDOG LLC testing centre (Irvine, California), profiles of microbiota were established through MiDOG LLC service, and all data and relevant fields were received in electronic transformation and through email.

Author contribution

Kerem Ural: Conceptualization, data curation, methodology; supervision; visualization; and writing; original draft preparation and writing; review and editing. Hasan Erdogan: Methodology; data curation; visualization; writing; review and editing. Songul Erdogan: Data curation; writing; review and editing.

Conflict of interest

There is no conflict of interest, including financial, personal, or other relationships, with other persons or organizations.

References

Bay L, Barnes CJ, Fritz BG, Thorsen J, Restrup MEM, Rasmussen L, Sørensen JK, Hesselvig AB, Odgaard A, Hansen AJ, Bjarnsholt T. 2020. Universal dermal microbiome in human skin. MBio. 11(1):e02945-19.https://doi.org/10.1128/mbio.02945-19

Callewaert C, Knödlseder N, Karoglan A, Güell M, Paetzold B. 2021. Skin microbiome transplantation and manipulation: Current state of the art. Computational and Structural Biotechnology Journal. 19:624-31. https://doi.org/10.1016/j.csbj.2021.01.001

Cho SS, Finocchiaro ET. 2010. Handbook of prebiotics and probiotics ingredients. U. S. A, CRC Press. Retrieved.

Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. 2009. Bacterial community variation in human body habitats across space and time. Science. 326:1694-7. https://doi.org/10.1126/science.1177486

D’hoe K, Vet S, Faust K, Moens F, Falony G, Gonze D, Lloréns-Rico V, Gelens L, Danckaert J, De Vuyst L, Raes J. 2018. Integrated culturing, modeling and transcriptomics uncovers complex interactions and emergent behavior in a three-species synthetic gut community. Elife. 7:e37090. https://doi.org/10.7554/eLife.37090

Dréno B, Araviiskaia E, Berardesca E, Gontijo G, Sanchez Viera M, Xiang LF, Martin R, Bieber T.2016. Microbiome in healthy skin, update for dermatologists. Journal of the European Academy of Dermatology and Venereology. 30(12):2038-47. https://doi.org/10.1111/jdv.13965

Esteban J, Nieto E, Calvo R, Fernández-Robals R, Valero-Guillén PL, Soriano F. 1999. Microbiological characterization and clinical significance of Corynebacteriumamycolatum strains. European Journal of Clinical Microbiology & Infectious Diseases. 18(7):518-21. https://doi.org/10.1007/s100960050336

Grice EA, Kong HH, Conlan S, Deming CB, Davis J, YoungAC, NISC Comparative Sequencing Program, Bouffard GG, Blakesley RW, Murray PR, Green ED, Turner ML, Segre JA. 2009. Topographical and temporal diversity of the human skin microbiome. Science. 324(5931):1190-2. https://doi.org/10.1126/science.1171700

Grice EA, Kong HH, Renaud G, Young AC, NISC Comparative Sequencing Program, Bouffard GG, Blakesley RW, Wolfsberg TG, Turner ML, Segre JA. 2008. A diversity profile of the human skin microbiota. Genome Research. 18(7):1043-50. https://doi.org/10.1101/gr.075549.107

Grice EA, Segre JA. 2011. The skin microbiome. Nature Reviews Microbiology. 9:244-53. https://doi.org/10.1038/nrmicro2537

Gunal M, Yayli G, Kaya O, Karahan N, Sulak O. 2006. The effects of antibiotic growth promoter, probiotic or organic acid supplementation on performance, intestinal microflora and tissue of broilers. International Journal of Poultry Science. 5:149-55. https://doi.org/10.9323/ijps.2006.149.155

Hammond AM, Monir RL, Schoch JJ. 2021. The role of the pediatric cutaneous and gut microbiomes in childhood disease: A review. Seminars in Perinatology. 45(6):151452. https://doi.org/10.1016/j.semperi.2021.151452

Hoek M. v, Merks RMH. 2017. Emergence of microbial diversity due to cross-feeding interactions in a spatial model of gut microbial metabolism. BMC Systems Biology. 11(1):1-18. https://doi.org/10.1186/s12918-017-0430-4

Inoue H, Someno T, Kawada M, Ikeda D. 2010. Citric acid inhibits a bacterial ceramidase and alleviates atopic dermatitis in an animal model. The Journal of Antibiotics. 63(10):611-13. https://doi.org/10.1038/ja.2010.91

Liang X, Ou C, Zhuang J, Li J, Zhang F, Zhong Y, Chen Y. 2021. Interplay Between Skin Microbiota Dysbiosis and the Host Immune System in Psoriasis: Potential Pathogenesis. Frontiers in Immunology. 12:764384. https://doi.org/10.3389/fimmu.2021.764384

Louis P, Flint HJ. 2017. Formation of propionate and butyrate by the human colonic microbiota. Environmental Microbiology. 19(1):29-41. https://doi.org/10.1111/1462-2920.13589

Martín A, Sierra MP, González JL, Arévalo MÁ. 2004. Identification of allergens responsible for canine cutaneous adverse food reactions to lamb, beef and cow's milk. Veterinary Dermatology. 15(6):349-56. https://doi.org/10.1111/j.1365-3164.2004.00404.x

Morris BE, Henneberger R, Huber H, Moissl-Eichinger C. 2013. Microbial syntrophy: interaction for the common good. FEMS Microbiology Reviews. 37(3):384-406. https://doi.org/10.1111/1574-6976.12019

Nakatsuji T, Chiang HI, Jiang SB, Nagarajan H, Zengler K, Gallo RL. 2013. The microbiome extends to subepidermal compartments of normal skin. Nature Communications. 4:1431. https://doi.org/10.1038/ncomms2441

Ogai K, Nagase S, Mukai K, Iuchi T, Mori Y, Matsue M, Sugitani K, Sugama J, Okomoto S. 2018. A comparison of techniques for collecting skin microbiome samples: swabbing versus tape-stripping. Frontiers in Microbiology. 9:2362. https://doi.org/10.3389/fmicb.2018.02362

Olivry T, Mueller RS. 2019.Critically appraised topic on adverse food reactions of companion animals (7): signalment and cutaneous manifestations of dogs and cats with adverse food reactions. BMC Veterinary Research. 15(1):140. https://doi.org/10.1186/s12917-019-1880-2

Olivry T, Saridomichelakis M, Nuttall T, Bensignor E, Griffin CE, Hill PB, International Committee on Allergic Diseases of Animals (ICADA).2014. Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs. Veterinary Dermatology. 25(2):77-e25. https://doi.org/10.1111/vde.12107

Perin B, Addetia A, Qin X. 2019. Transfer of skin microbiota between two dissimilar autologous microenvironments: A pilot study. PLoS One. 14(12):e0226857. https://doi.org/10.1371/journal.pone.0226857

Rodrigues Hoffmann A, Patterson AP, Diesel A, Lawhon SD, Ly HJ, Elkins Stephenson C, Mansell J, Steiner JM, Dowd SE, Olivry T, Suchodolski JS. 2014. The skin microbiome in healthy and allergic dogs. PloS One. 9(1):e83197. https://doi.org/10.1371/journal.pone.0083197

Rondelli MCH, Oliveira MCdeC, daSilva FL, Palacios Junior RJG, Peixoto MC, Carciofi AC, Tinucci-Costa M.2015.A retrospective study of canine cutaneous food allergy at a Veterinary Teaching Hospital from Jaboticabal, São Paulo, Brazil. Ciência Rural. 45(10):1819-25. https://doi.org/10.1590/0103-8478cr20140440

Rungjang A, Meephansan J, Payungporn S, Sawaswong V, Chanchaem P, Pureesrisak P, Wongpiyabovorn J, Thio HB. 2022. Skin Microbiota Profiles from Tape Stripping and Skin Biopsy Samples of Patients with Psoriasis Treated with Narrowband Ultraviolet B. Clinical, Cosmetic and Investigational Dermatology. 15:1767-1778. https://doi.org/10.2147/CCID.S374871

Russel JB, Diez-Gonzalez F. 1998. The effect of fermentation acids on bacterial growth. Advances in Microbial Physiology. 39:205-34. https://doi.org/10.1016/S0065-2911(08)60017-X

Rybníček J, Lau‐Gillard PJ, Harvey R, Hill PB. 2009. Further validation of a pruritus severity scale for use in dogs. Veterinary Dermatology. 20(2):115-22. https://doi.org/10.1111/j.1365-3164.2008.00728.x

Schaub B, Lauener R, von Mutius E. 2006. The many faces of the hygiene hypothesis. Journal of Allergy and Clinical Immunology. 117(5):969-78. https://doi.org/10.1016/j.jaci.2006.03.003

Su LC, Xie Z, Zhang Y, Nguyen KT, Yang J. 2014. Study on the antimicrobial properties of citrate-based biodegradable polymers. Frontiers in Bioengineering and Biotechnology. 2:23. https://doi.org/10.3389/fbioe.2014.00023

Tang S, Prem A, Tjokrosurjo J, Sary M, Van Bel MA, Rodrigues-Hoffmann A, Kavanagh M, Wu G, Van Eden ME, Kurumbeck JA. 2020. The canine skin and ear microbiome: A comprehensive survey of pathogens implicated in canine skin and ear infections using a novel next-generation-sequencing-based assay. Veterinary Microbiology. 247:108764. https://doi.org/10.1016/j.vetmic.2020.108764

Tizard IR, Jones SW. 2018. The microbiota regulates immunity and immunologic diseases in dogs and cats. The Veterinary Clinics of North America: Small Animal Practice. 48(2):307-22. https://doi.org/10.1016/j.cvsm.2017.10.008

Ural K, Erdoğan H, Erdoğan S. 2022. Heterologue skin microbiota transplantation for treatment of sarcoptic mange in two dogs with zoonotic transmission. Bozok Veterinary Sciences. 3(2):52-6. https://doi.org/10.58833/bozokvetsci.1207900

Ural K, Erdoğan H, Erdoğan S. 2023. Skin microbiota transplantation by Nivea Refining Clear-Up Strips could reverse erythema scores in dogs with atopic dermatitis: Novel strategy for skin microbiome manipulation. Turkiye Klinikleri Journal of Veterinary Sciences.14(1):11-7. https://doi.org/10.5336/vetsci.2022-93888

Zeeuwen PL, Boekhorst J, van den Bogaard EH, de Koning HD, van de Kerkhof PM, Saulnier DM, van Swam II, van Hijum SA, Kleerebezem M, Schalkwijk J, Timmerman HM. 2012. Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biology. 13:R101. https://doi.org/10.1186/gb-2012-13-11-r101